Skip to main content
. 2015 Jun 4;2:115–122. doi: 10.1016/j.bbrep.2015.05.012

Fig. 4.

Fig. 4

Antibody and pravastatin binding on MDR1-incorporated tBLM by SPR. (A) (●) Binding result of anti-MDR1 monoclonal antibody on MDR1-incorporated tBLM. (■) Binding result of anti-MDR1 antibody on MDR1-free tBLM. (▲) Binding result of anti-Pin-1 (G8) mouse monoclonal antibody on MDR1-incorporated tBLM. (B) Binding result of (○) 0.05 mg/mL and (□) 0.01 mg/mL pravastatin solutions on MDR1-incorporated tBLM and binding of 0.05 mg/mL of pravastatin (∆) on MDR1-free bilayers.